{"id":"W2060275730","doi":"10.1038/nature07397","title":"Activating mutations in ALK provide a therapeutic target in neuroblastoma","year":2008,"lang":"en","type":"article","venue":"Nature","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":892,"is_retracted":false,"has_abstract":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Neuroblastoma; Anaplastic lymphoma kinase; Cancer research; Biology; Gene knockdown; Molecular biology; Small hairpin RNA; Mutation; Tyrosine kinase; Cell culture; Gene; Signal transduction; Cell biology; Genetics; Medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01921542182137839,"score_gpt":0.3121136169284821,"score_spread":0.2928981951071037,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}